loader2
Login Open ICICI 3-in-1 Account
Open ICICI 3-in-1 Account

MACLEODS PHARMACEUTICALS LTD IPO

IPO Details

-
-
To be announced
-
₹ To be announced
₹ To be announced

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

- The company engages in developing,manufacturing and marketing a wide range of formulations including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
- Were the 7th largest in the Indian pharmaceutical market(IPM) by domestic sales for the six months ended September 30,2021 (Source: IQVIA Dataset and Company DRHP)

Strengths & Risks

Strengths (3)

One of the leading and fast growing companies with significant presence in the IPM
Outperformed the IPM with domestic sales growth at a CAGR of 15.3% from fiscal 2011 to fiscal 2021, compared to 10.8% sales growth of the IPM in the same period (Source:IQVIA Dataset, Company DRHP)

Risks (2)

The company may experience a shortfall in the supply of raw materials or an increase in their prices, or of other input costs.
The raw materials used in the manufacture of products, including packaging materials, are subject to supply disruptions and price volatility caused by various factors, such as commodity market fluctuations, the quality and availiability of such materials, currency fluctuations, consumer demand, and the regulatory environment. (Source: Company DRHP)

  • One of the leading and fast growing companies with significant presence in the IPM
    Outperformed the IPM with domestic sales growth at a CAGR of 15.3% from fiscal 2011 to fiscal 2021, compared to 10.8% sales growth of the IPM in the same period (Source:IQVIA Dataset, Company DRHP)

  • Proven track record of building brands
    Demonstrated capabilities in building brands and had a portfolio of 595 brands in IPM between fiscal 2017 and fiscal 2021 (Source: Company DRHP)

  • Diversified presence across global markets with calibrated business model
    The company operations are diverse in terms of geography, product portfolio, and business model, with revenue form operations outside India representing 48.27% and 36.07% of total revenue from opeations, in Fiscal 2021 and the six months ended september 30,2021,respectively. Distributes products across more than 170 countries through differentiated business models for each key markets. (Source: Company DRHP)

  • The company may experience a shortfall in the supply of raw materials or an increase in their prices, or of other input costs.
    The raw materials used in the manufacture of products, including packaging materials, are subject to supply disruptions and price volatility caused by various factors, such as commodity market fluctuations, the quality and availiability of such materials, currency fluctuations, consumer demand, and the regulatory environment. (Source: Company DRHP)

  • The company could experience a material slowdown or shutdown in manufacturing or R&D operations
    Business is dependent on its ability to manage manufacturing and R&D facilities, which are subject to various operating risks and factors outside control including breakdown and/or failure of equipment or industrial accidents, severe weather conditions, natural disasters etc.(Source: Company DRHP)

Financials

Net Worth
Total Income
Total Borrowings
Profit After tax
Basic Earning per Share (EPS)

Industry Overview

-Overview of Indian Pharmaceutical Market(IPM) : The size of IPM has increased from ₹ 483 billion in fiscal 2011 to ₹ 1343 billion in fiscal 2021 at ~11% CAGR over fiscal 2011-21. The IPM is forecast to grow at a CAGR of 10-11% to reach ₹2150-226 billion by fiscal 2026.(Source IQVIA SSA)

Macleods Pharmaceuticals Ltd IPO

-
To be announced

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

Download
ICICI Direct app

market app

*The financials mentioned above are sourced from DRHP/ RHP documents.

✕
Application status